August 5, 2022 CBD is a non-psychoactive cannabinoid that may have highly beneficial medicinal properties.
The cannabis-derived compound cannabidiol (CBD) may reduce the severity of treatment-resistant anxiety by around 50 percent in young people, the results of a new pilot study indicate. Appearing in the Journal of Clinical Psychiatry, the research involved patients between the ages of 12 and 25, none of whom experienced any major side effects when using the non-psychoactive cannabinoid.
